glp-1 medications approved for diabetes and weight loss 2025 are marketed to help you lose weight, but one may be better at it than the rest, according to a new meta-analysis from the UGA College of Pharmacy. Tirzepatide, better Indications for GLP-1/GIP RA Summary

When this happens, gastritis symptoms occur, which can include the following, according to New York Presbyterian: Loss of appetite Indigestion Bloating Abdominal pain Vomiting or stomach cramps after eating Constipation or diarrhea in some people According to Medline Plus, these symptoms may last only a few days or linger for months

(Photo by Shalina Chatlani/Stateline) Massachusetts and Rhode Island are considering dropping GLP-1 drugs for obesity treatment from their Medicaid programs, continuing a trend of states that have stopped coverage of these expensive medications

Diabetes or metabolic syndromes: People living with diabetes or metabolic syndromes, such as high blood pressure, high blood sugar, excess body fat around the waist, and irregular cholesterol levels, may also experience inflammation in the body, which can impact the health of the shoulder and rotator cuff, particularly leading to adhesive capsulitis (frozen shoulder)

Retatrutide, tirzepatide, and semaglutide all reduce food noise by: Increasing activity in satiety neurons (POMC/CART neurons) Decreasing activity in hunger neurons (NPY/AgRP neurons) Reducing ghrelin secretion from the stomach Slowing gastric emptying so food stays in the stomach longer The result: the food noise quiets noticeably within days of the first injection

It can be taken directly or diluted in a glass of water